Skip to main navigation

Press Releases

Press Releases

Year

Aug 24, 2023

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 08, 2023

Personalis Reports Second Quarter 2023 Financial Results

Aug 01, 2023

Personalis to Participate at Upcoming Investor Conferences

Jul 25, 2023

Personalis to Announce Second Quarter 2023 Financial Results

Jun 26, 2023

Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics

Jun 13, 2023

Dr. Kenneth J. Widder Joins Personalis Board of Directors

May 30, 2023

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

May 16, 2023

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 03, 2023

Personalis Reports First Quarter 2023 Financial Results

May 02, 2023

Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Displaying 11 - 20 of 31

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website